Statins and Cardiovascular Primary Prevention in CKD | Zendy

Rupert Major | Zendy; Chee Kay Cheung | Zendy; Laura J. Gray | Zendy; Nigel J. Brunskill | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Statins and Cardiovascular Primary Prevention in CKD

Author(s) -

Rupert Major,

Chee Kay Cheung,

Laura J. Gray,

Nigel J. Brunskill

Publication year - 2015

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.07460714

Subject(s) - medicine , meta analysis , population , confidence interval , kidney disease , subgroup analysis , placebo , randomized controlled trial , stroke (engine) , medline , physical therapy , alternative medicine , pathology , mechanical engineering , environmental health , engineering , political science , law

Multiple meta-analyses of lipid-lowering therapies for cardiovascular primary prevention in the general population have been performed. Other meta-analyses of lipid-lowering therapies in CKD have also been performed, but not for primary prevention. This meta-analysis assesses lipid-lowering therapies for cardiovascular primary prevention in CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research